Japan, Jan. 16 -- GENERAL HOSPITAL CORP,DANA FARBER CANCER INSTITUTE INC has got intellectual property rights for 'COMPOSITIONS AND METHODS OF IDENTIFYING TUMOR SPECIFIC NEOANTIGENS.' Other related details are as follows:

Application Number: JP,2022-000837

Category (FI): A61K35/15,A61K35/15@Z,A61K39/00@H,A61K39/39,A61K39/395@N,A61K45/00,A61P35/00,A61P35/02,A61P37/04,A61P43/00,111,A61P43/00,121,A61P7/00,C07K14/82,C12N15/12,C12Q1/02,G01N33/50@P,G01N33/68

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Jan. 6, 2022

Publication Date: March 17, 2022

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.